| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $8,164,950 ) |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | U42OD010442 | Establishment of a SPF Rhesus Macaque Colony | 000 | 22 | NIH | 2/24/2023 | $2,417,980 |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01HL145411 | Predicting tuberculosis outcomes using genotypic and biomarker signatures | 001 | 5 | NIH | 1/14/2023 | $729,753 |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 000 | 2 | NIH | 2/8/2023 | $391,538 |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 000 | 2 | NIH | 2/8/2023 | $403,691 |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01HL145411 | Predicting tuberculosis outcomes using genotypic and biomarker signatures | 002 | 5 | NIH | 3/11/2023 | $72,915 |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI170197 | Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS | 000 | 2 | NIH | 1/18/2023 | $989,774 |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P30AI168439 | Interdisciplinary NexGen TB research Advancement Center (IN-TRAC) | 000 | 2 | NIH | 2/2/2023 | $1,150,146 |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI048071 | Mapping Drug Resistance Genes in Plasmodium falciparum | 000 | 21 | NIH | 11/7/2022 | $970,185 |
| | 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | K01OD031898 | Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic | 000 | 3 | NIH | 1/14/2023 | $188,995 |
| | 2023 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 000 | 24 | NIH | 11/8/2022 | $0 |
| | 2023 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | K01OD026529 | Pathogenesis of and host response to chikungunya virus infection of the central nervous system | 001 | 6 | NIH | 2/15/2023 | $118,541 |
| | 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R37AI048071 | Mapping Drug Resistance Genes in Plasmodium falciparum | 000 | 20 | NIH | 11/7/2022 | $0 |
| | 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | C06OD030079 | Significant expansion of the SNPRC Specific Pathogen Free Rhesus Macaque Colony for AIDS research | 001 | 1 | NIH | 1/30/2023 | $0 |
| | 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | C06OD030079 | Significant expansion of the SNPRC Specific Pathogen Free Rhesus Macaque Colony for AIDS research | 000 | 1 | NIH | 11/2/2022 | $0 |
| | 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI150445 | Determining the efficacy of a novel TB diagnostic test to monitor treatment success in drug resistant TB patients | 000 | 2 | NIH | 1/17/2023 | $0 |
| | 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI145539 | Effect of HIV infection on M.tuberculosis granuloma formation and evolution | 000 | 2 | NIH | 1/30/2023 | -$1,789 |
| | 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI134245 | Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma | 001 | 5 | NIH | 1/18/2023 | $851,458 |
| | 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI123434 | Genetic Basis of Praziquantel Resistance | 000 | 5 | NIH | 1/30/2023 | $0 |
| | 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI123047 | Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function-Diversity Supplement | 001 | 5 | NIH | 1/30/2023 | -$1,734 |
| | 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI123047 | Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function-Diversity Supplement | 000 | 5 | NIH | 1/30/2023 | -$10,454 |
| | 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R56AI150371 | HIV- induced long non-coding RNAs in viral replication and immune response | 000 | 1 | NIH | 1/30/2023 | $0 |
| | 2023 | 2019 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI135284 | Attenuation of Lassa Virus Via Codon Deoptimization | 001 | 3 | NIH | 1/27/2023 | $1,601 |
| | 2023 | 2019 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI135284 | Attenuation of Lassa Virus Via Codon Deoptimization | 000 | 3 | NIH | 10/28/2022 | -$1,601 |
| | 2023 | 2019 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R24OD020347 | Research to Improve and Standardize Marmoset Nutrition and Dietary Husbandry | 000 | 4 | NIH | 1/30/2023 | -$57,739 |
| | 2023 | 2019 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI112851 | Mechanism and Evolution of Filoviral Monoclonal Affinity Reagent Sandwich Assays | 000 | 5 | NIH | 1/30/2023 | -$680 |
| | 2023 | 2019 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI138793 | Molecular Determinants of HIV hypermutation | 000 | 3 | NIH | 1/30/2023 | -$1,975 |
| | 2023 | 2018 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R56DK114703 | Defining the Normal Range of Postprandial Metabolic Risk: Multi-omic and multi-tissue Analysis after a Mixed Meal | 000 | 2 | NIH | 1/30/2023 | -$45,656 |
|
| Issue Date FY: 2022 ( Subtotal = $28,979,218 ) (Continued on the next page) |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | U42OD010442 | Establishment of a SPF Rhesus Macaque Colony | 000 | 21 | NIH | 2/1/2022 | $2,092,484 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 000 | 1 | NIH | 4/5/2022 | $422,392 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 000 | 1 | NIH | 4/5/2022 | $403,691 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 005 | 24 | NIH | 4/29/2022 | $7,483,557 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 008 | 24 | NIH | 6/6/2022 | $2,256,688 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 011 | 24 | NIH | 8/3/2022 | $499,999 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 009 | 24 | NIH | 7/13/2022 | $73,260 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 010 | 24 | NIH | 8/1/2022 | $499,944 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 012 | 24 | NIH | 8/16/2022 | $73,260 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 007 | 24 | NIH | 6/1/2022 | $419,864 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center | 012 | 24 | NIH | 8/16/2022 | -$73,260 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | S10OD032443 | Dual Beckman Coulter DxH 690T and Beckman Coulter DxH 560 AL | 000 | 1 | NIH | 9/20/2022 | $85,775 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI170148 | Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection | 000 | 1 | NIH | 8/18/2022 | $412,506 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | K01OD031898 | Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic | 001 | 2 | NIH | 5/17/2022 | $18,896 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | K01OD031898 | Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic | 000 | 2 | NIH | 1/20/2022 | $170,060 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI134245 | Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma | 002 | 6 | NIH | 4/15/2022 | $1,260,778 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AG065546 | Microbiome-mediated therapies for aging and healthspan in marmosets | 000 | 3 | NIH | 6/3/2022 | $748,508 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | F32AI152348 | Linking Receptor-Mediated Phagocytosis and cAMP Pathways in Macrophage Responses to Tuberculosis | 001 | 3 | NIH | 5/23/2022 | $1,360 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | F32AI152348 | Linking Receptor-Mediated Phagocytosis and cAMP Pathways in Macrophage Responses to Tuberculosis | 000 | 3 | NIH | 3/21/2022 | $77,793 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | F99AG079802 | Elucidate the adverse impact of mitochondria-induced oxidative stress in molecular and cellular determinants in the aging lung, driving susceptibility to Mycobacterium tuberculosis infection | 001 | 1 | NIH | 9/22/2022 | $0 |
| | 2022 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | F99AG079802 | Elucidate the adverse impact of mitochondria-induced oxidative stress in molecular and cellular determinants in the aging lung, driving susceptibility to Mycobacterium tuberculosis infection | 000 | 1 | NIH | 9/22/2022 | $37,532 |
|
